Gene · 6249
Papers2,568
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,568
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Centralized Space Learning for open-set computer-aided diagnosis. | Sci Rep | 2023 | 36717731 | PubTator, text mining | PubMed |
| Endplate role in the degenerative disc disease: A brief review. | World J Clin Cases | 2023 | 36687189 | PubTator, text mining | PubMed |
| VisdaNet: Visual Distillation and Attention Network for Multimodal Sentiment Classification. | Sensors (Basel) | 2023 | 36679456 | PubTator, text mining | PubMed |
| A New Potential Therapeutic Target for Cancer in Ubiquitin-Like Proteins-UBL3. | Int J Mol Sci | 2023 | 36674743 | PubTator, text mining | PubMed |
| MHC Class II Presentation in Autoimmunity. | Cells | 2023 | 36672249 | PubTator, text mining | PubMed |
| Depletion of the RNA-binding protein PURA triggers changes in posttranscriptional gene regulation and loss of P-bodies. | Nucleic Acids Res | 2023 | 36651277 | PubTator, text mining | PubMed |
Short- and Long-Term Outcomes of Indocyanine Green Fluorescence Navigation- Versus Conventional-Laparoscopic Hepatectomy for Hepatocellular Carcinoma: A Propensity Score-Matched, Retrospective, Cohort Study. | Ann Surg Oncol | 2023 | 36645540 | PubTator, text mining | PubMed |
| RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives. | Pharmacol Ther | 2023 | 36632846 | PubTator, text mining | PubMed |
| Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China. | Technol Cancer Res Treat | 2023 | 36628459 | PubTator, text mining | PubMed |
| Functional studies of HLA and its role in SARS-CoV-2: Stimulating T cell response and vaccine development. | Life Sci | 2023 | 36621539 | PubTator, text mining | PubMed |
| CLASP2 facilitates dynamic actin filament organization along the microtubule lattice. | Mol Biol Cell | 2023 | 36598814 | PubTator, text mining | PubMed |
| Mitochondria-localized lncRNA HITT inhibits fusion by attenuating formation of mitofusin-2 homotypic or heterotypic complexes. | J Biol Chem | 2023 | 36567017 | PubTator, text mining | PubMed |
| VASH1-SVBP and VASH2-SVBP generate different detyrosination profiles on microtubules. | J Cell Biol | 2023 | 36512346 | PubTator, text mining | PubMed |
| Phosphorylation of the novel mTOR substrate Unkempt regulates cellular morphogenesis. | J Biol Chem | 2023 | 36509146 | PubTator, text mining | PubMed |
| α-Tubulin detyrosination links the suppression of MCAK activity with taxol cytotoxicity. | J Cell Biol | 2023 | 36459065 | PubTator, text mining | PubMed |
| CLIP: accurate prediction of disordered linear interacting peptides from protein sequences using co-evolutionary information. | Brief Bioinform | 2023 | 36458437 | PubTator, text mining | PubMed |
| Endothelial progenitor cells in the host defense response. | Pharmacol Ther | 2023 | 36436689 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. | Nat Biotechnol | 2023 | 36217030 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6249/papers?page=15